top of page
  • Twitter
solo TCR Black logo.png

In-Depth Coverage Of The Irish And European Markets

Regulating the Cannabis Potency Race


Image of cannabis bud with text " headline: Regulating the potency race"

In the ever-evolving landscape of the cannabis industry, one cannot help but draw parallels between the current recreational-use scenarios and the post-Prohibition era of alcohol. While some may shy away from comparing the two, it's intriguing to observe the trajectory of cannabis potency and its impact on consumer preferences. Nearly a decade after Colorado blazed a trail by legalising adult-use cannabis, it seems that the focus on potency remains undeniably fixated on a single cannabinoid: THC. But is this emphasis on THC percentages painting the whole picture?


In the early years, cannabis enthusiasts often spoke about the "entourage effect," a term initially used to describe the balance between THC and CBD, but later evolved to encompass a harmonious blend of cannabinoids and terpenes. It's a delicate symphony of compounds that contribute to the unique experiences and effects of different cannabis strains. Yet, in the midst of this intricate interplay of nature's chemistry, the spotlight still hovers predominantly over THC percentages. It's not uncommon to encounter consumers seeking strains with THC potencies soaring above the 30% mark, even approaching Guinness Book of World Records territory.


In certain states in the US, there exists a margin of error for allowable THC and cannabinoid content variance on product labels. For example, in Arizona, the variance for medical cannabis is +/- 20%, while in Michigan, it's +/- 15%. California offers an even tighter margin at +/- 10%. This flexibility, coupled with limited monitoring and enforcement by regulators, leaves room for potential discrepancies in reported cannabinoid content. Moreover, it's essential to recognise that THC potency doesn't necessarily equate to a superior product. The concentration of THC in cannabis products plays a smaller role in overall potency than one might assume. After all, much of the THC is exhaled during consumption.


However, let's pause for a moment to consider the broader context.



Is the THC percentage really the ultimate measure of a cannabis strain's quality and potency?


The THC percentage is often considered a crucial factor when assessing a cannabis strain's quality and potency, but it may not be the ultimate measure. While THC is the primary psychoactive compound responsible for the euphoric "high," it's just one piece of the intricate puzzle. The true potency and quality of a cannabis strain depend on the collective interplay of various cannabinoids and terpenes. These compounds work together in what's known as the entourage effect, influencing the overall experience and therapeutic effects of the strain. By solely focusing on THC percentage, consumers might miss out on the full spectrum of benefits that a balanced blend of cannabinoids and terpenes can offer. It's crucial to consider the holistic profile of a cannabis strain, appreciating the synergistic effects of all its components.



How can regulation help us steer clear of the cannabis potency race?


When it comes to cannabis potency and steering clear of the potency race observed in the US, regulation plays a crucial role.


While THC levels have become the go-to metric for measuring cannabis strength, it's essential to consider other factors to create a well-rounded understanding of cannabis's potential benefits and risks. Regulation plays a critical role in achieving this balance. Routine testing and monitoring of cannabis products are essential to ensure accurate potency information for consumers. While challenges exist, advancements in sampling and testing methodologies are promising. Regulating authorities should conduct independent testing, supported by taxation and licensing fees, to cover the cost burden.


Transparency is key to responsible cannabis consumption. All retail products must be clearly labelled with potency information, including THC and CBD content, along with related risks. Simplified numerical strength guides can provide further assistance to consumers in making informed choices. However, imposing arbitrary upper limits on THC content can be problematic. Instead, a combination of strict product testing, consumer education, responsible retailing, and variable tax rates may better moderate risks. Concentrates present a unique challenge, given their rising popularity. Licensing and regulating their production can offer a safer alternative to risky home extraction.


When considering CBD content and THC: CBD ratios, caution is needed. Establishing enforceable limits for these elements remains challenging due to a lack of robust scientific evidence. Instead, licensed products should include a CBD "buffer" to provide a balanced experience for consumers. In the evolving landscape of cannabis potency, effective regulation should focus on consumer education, responsible practices, and promoting informed decision-making. By embracing transparency and fostering a balanced approach, the industry can navigate the potency race while ensuring the well-being of cannabis users and encouraging a safe and thriving market.



Sources:


47 views1 comment

1 Comment


Greetings from Aachen, Germany where we are setting up Cannabis Social Club Aachen. The legislation is at the early stages, but it's clear the German authorities are not very well informed about the strength and strains of cannabis they want to see legalised.

The Germans could learn a lot from Luxembourg where private consumption and the growing of cannabis is not related in any way to the strength of the strain. The current proposal is for batch sampling of cannabis grown by the club, but we don't want to supplx members. Instead they should get to grow their three plants and share any excess with other members.


We will end up growing what is most in demand. I have created…


Like
bottom of page